Amendment 0004 Solicitation SPE2D2-24-R-0016(Bicalutamide) CANCELLED

SOL #: SPE2D2-24-R-0016Solicitation

Overview

Buyer

DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Dec 23, 2024
2
Last Updated
Jul 10, 2025
3
Submission Deadline
Feb 14, 2025, 8:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

July 10,2024, Amendment 004 is hereby issued to cancel the subject solicitation in it's entirety

The Defense Logistics Agency is  issue a solicitation for a national requirements contract for Bicalutamide 50MG tablets in bottle counts of 30 and 500. Procurement details follow.

DESCRIPTION                                                               EST QTY (YR)

Bicalutamide 50 MG Tablet – 30 Count                               23,529

Bicalutamide 50 MG Tablet – 500 Count                               1961

This is an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.  

A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/

Interested parties should contact Keith Ryales (215-737-9199) (Keith. Ryales@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is TBA. DLA reserves the right to issue the solicitation before or after the projected solicitation date.

NOTE:

\i) Amendment 0001 is Null and Void. Amendment 0001 has been deleted due to systemic issue, this amendment 0002 replaces 0001.
ii) The Revised Solicitation document is included / embedded in this file. Access the files(s) by following the instruction in order below:


Using Adobe Acrobat- 1. Go to thumbnail 2. Go to Attachments:(view files attached) (Attachments are under the Paperclip symbol)
THIS AMENDMENT INCLUDES THE FOLLOWNG: 1) Solicitation Closing Date is herein 02/07/2025 3:00 pm
2) Page 84 of 97  is has in revised 
3) All other information in the original solicitation remains the same.

People

Points of Contact

Keith RyalesPRIMARY

Files

Files

Download
Download
Download
Download

Versions

Version 4Viewing
Solicitation
Posted: Jul 10, 2025
Version 3
Solicitation
Posted: Feb 4, 2025
View
Version 2
Solicitation
Posted: Jan 27, 2025
View
Version 1
Solicitation
Posted: Dec 23, 2024
View
Amendment 0004 Solicitation SPE2D2-24-R-0016(Bicalutamide) CANCELLED | GovScope